← All Sponsors
SPONSOR

Salubris Biotherapeutics Inc

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
NCT07221513 Phase 2
Recruiting

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

HFrEF - Heart Failure With Reduced Ejection Fraction
United States View Trial →